We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.7821 | 0.83% | 94.9121 | 2,145 | 12:42:26 |
From Mar 2023 to Mar 2025
By Ben Glickman
Shares of Axonics rose on Monday after the company agreed be acquired for $3.7 billion in cash by Boston Scientific.
The stock was up 20% to $69.25, its highest intraday level since December 2022. Shares are up about 26% in the last year.
Boston Scientific said before the open it would pay $71 per share in cash for Axonics, which is focused on developing products to address bladder and bowel issues. Axonics will become a wholly-owned subsidiary of Boston Scientific.
The deal is expected to close in the first half of this year.
Axonics said Monday it now expects fourth-quarter revenue of $109.3 million to $109.7 million. Analysts polled by FactSet expected fourth-quarter revenue of $105.6 million.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
January 08, 2024 11:21 ET (16:21 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
